Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2025-12-26 @ 1:26 AM
NCT ID: NCT01491633
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01491633
Study Brief: Dasatinib in Advanced Squamous Cell Lung Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dasatinib Dasatinib 140 mg by mouth each day Dasatinib: 140 mg orally, daily in 28 day cycles None None 2 5 5 5 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hemoptysis None Respiratory, thoracic and mediastinal disorders None View
Death None General disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Pleural effusion None Respiratory, thoracic and mediastinal disorders None View
Dyspnea None Respiratory, thoracic and mediastinal disorders None View
Fatigue None General disorders None View
Elevated LFTs None Gastrointestinal disorders None View
Anorexia None General disorders None View
Nausea None Gastrointestinal disorders None View